260 related articles for article (PubMed ID: 18925456)
41. Clinical and pathological findings of non-Val30Met TTR type familial amyloid polyneuropathy in Japan.
Ikeda S; Takei Y; Tokuda T; Nakazato M; Ando Y
Amyloid; 2003 Aug; 10 Suppl 1():39-47. PubMed ID: 14640041
[TBL] [Abstract][Full Text] [Related]
42. A Trans-acting Factor May Modify Age at Onset in Familial Amyloid Polyneuropathy ATTRV30M in Portugal.
Alves-Ferreira M; Coelho T; Santos D; Sequeiros J; Alonso I; Sousa A; Lemos C
Mol Neurobiol; 2018 May; 55(5):3676-3683. PubMed ID: 28527106
[TBL] [Abstract][Full Text] [Related]
43. Transthyretin familial amyloid polyneuropathy.
Planté-Bordeneuve V; Kerschen P
Handb Clin Neurol; 2013; 115():643-58. PubMed ID: 23931808
[TBL] [Abstract][Full Text] [Related]
44. Presence of autoantibody against ATTR Val30Met after sequential liver transplantation.
Ando Y; Terazaki H; Haraoka K; Tajiri T; Nakamura M; Obayashi K; Misumi S; Shoji S; Hata K; Nakagawa K; Ishizaki T; Uemoto S; Inomata Y; Tanaka K; Okabe H
Transplantation; 2002 Mar; 73(5):751-5. PubMed ID: 11907422
[TBL] [Abstract][Full Text] [Related]
45. Type I (transthyretin Met30) familial amyloid polyneuropathy in Japan: early- vs late-onset form.
Koike H; Misu K; Ikeda S; Ando Y; Nakazato M; Ando E; Yamamoto M; Hattori N; Sobue G;
Arch Neurol; 2002 Nov; 59(11):1771-6. PubMed ID: 12433265
[TBL] [Abstract][Full Text] [Related]
46. [Familial amyloid polyneuropathy: clinicopathological aspects].
Koike H; Sobue G
Brain Nerve; 2014 Jul; 66(7):749-62. PubMed ID: 24998820
[TBL] [Abstract][Full Text] [Related]
47. Regional differences and similarities of FAP in Sweden.
Hellman U; Suhr O
Amyloid; 2012 Jun; 19 Suppl 1():53-4. PubMed ID: 22468675
[TBL] [Abstract][Full Text] [Related]
48. Familial amyloidosis with polyneuropathy type 1 caused by transthyretin mutation Val50Met (Val30Met): 4 cases in a non-endemic area.
Andrés N; Poza JJ; Martí Massó JF
Neurologia (Engl Ed); 2018; 33(9):583-589. PubMed ID: 27793437
[TBL] [Abstract][Full Text] [Related]
49. Late-onset familial amyloid polyneuropathy type I (transthyretin Met30-associated familial amyloid polyneuropathy) unrelated to endemic focus in Japan. Clinicopathological and genetic features.
Misu Ki; Hattori N; Nagamatsu M; Ikeda Si; Ando Y; Nakazato M; Takei Yi; Hanyu N; Usui Y; Tanaka F; Harada T; Inukai A; Hashizume Y; Sobue G
Brain; 1999 Oct; 122 ( Pt 10)():1951-62. PubMed ID: 10506096
[TBL] [Abstract][Full Text] [Related]
50. Transthyretin-related vitreous amyloidosis in different endemic areas.
Kawaji T; Ando Y; Ando E; Sandgren O; Suhr OB; Tanihara H
Amyloid; 2010 Sep; 17(3-4):105-8. PubMed ID: 21077797
[TBL] [Abstract][Full Text] [Related]
51. Cardiac and peripheral vasomotor autonomic functions in late-onset transthyretin Val30Met familial amyloid polyneuropathy.
Koike H; Nakamura T; Hashizume A; Nishi R; Ikeda S; Kawagashira Y; Iijima M; Katsuno M; Sobue G
J Neurol; 2017 Nov; 264(11):2293-2302. PubMed ID: 28983659
[TBL] [Abstract][Full Text] [Related]
52. [Application to transthyretin analysis].
Ueda M; Ando Y
Rinsho Byori; 2006 Jun; 54(6):601-8. PubMed ID: 16872010
[TBL] [Abstract][Full Text] [Related]
53. Three Turkish families with different transthyretin mutations.
Bekircan-Kurt CE; Güneş N; Yılmaz A; Erdem-Özdamar S; Tan E
Neuromuscul Disord; 2015 Sep; 25(9):686-92. PubMed ID: 26115788
[TBL] [Abstract][Full Text] [Related]
54. Sixty years of transthyretin familial amyloid polyneuropathy (TTR-FAP) in Europe: where are we now? A European network approach to defining the epidemiology and management patterns for TTR-FAP.
Parman Y; Adams D; Obici L; Galán L; Guergueltcheva V; Suhr OB; Coelho T;
Curr Opin Neurol; 2016 Feb; 29 Suppl 1(Suppl 1):S3-S13. PubMed ID: 26734951
[TBL] [Abstract][Full Text] [Related]
55. Secondary glaucoma in patients with familial amyloidotic polyneuropathy.
Kimura A; Ando E; Fukushima M; Koga T; Hirata A; Arimura K; Ando Y; Negi A; Tanihara H
Arch Ophthalmol; 2003 Mar; 121(3):351-6. PubMed ID: 12617705
[TBL] [Abstract][Full Text] [Related]
56. The genetic heterogeneity of hereditary transthyretin amyloidosis in a sample of the Brazilian population.
Lavigne-Moreira C; Marques VD; Gonçalves MVM; de Oliveira MF; Tomaselli PJ; Nunez JC; do Nascimento OJM; Barreira AA; Marques W
J Peripher Nerv Syst; 2018 Jun; 23(2):134-137. PubMed ID: 29520877
[TBL] [Abstract][Full Text] [Related]
57. TTR-related amyloid neuropathy: clinical, electrophysiological and pathological findings in 15 unrelated patients.
Luigetti M; Conte A; Del Grande A; Bisogni G; Madia F; Lo Monaco M; Laurenti L; Obici L; Merlini G; Sabatelli M
Neurol Sci; 2013 Jul; 34(7):1057-63. PubMed ID: 22592564
[TBL] [Abstract][Full Text] [Related]
58. [Diagnosis of familial amyloid polyneuropathy type I in Argentina].
Pérez G; Romero MC; Trigo P; Lendoire J; Imventarza O; Nesse A
Medicina (B Aires); 2008; 68(4):273-81. PubMed ID: 18786882
[TBL] [Abstract][Full Text] [Related]
59. Cardiac phenotype and clinical outcome of familial amyloid polyneuropathy associated with transthyretin alanine 60 variant.
Sattianayagam PT; Hahn AF; Whelan CJ; Gibbs SD; Pinney JH; Stangou AJ; Rowczenio D; Pflugfelder PW; Fox Z; Lachmann HJ; Wechalekar AD; Hawkins PN; Gillmore JD
Eur Heart J; 2012 May; 33(9):1120-7. PubMed ID: 21992998
[TBL] [Abstract][Full Text] [Related]
60. Amyloid fibril composition within hereditary Val30Met (p. Val50Met) transthyretin amyloidosis families.
Suhr OB; Wixner J; Anan I; Lundgren HE; Wijayatunga P; Westermark P; Ihse E
PLoS One; 2019; 14(2):e0211983. PubMed ID: 30811423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
